Abstract
In the wake of COVID-19, morbidity and mortality due to Opioid Use Disorder (OUD) is beginning to emerge as a second wave of deaths of despair. Medication assisted treatment (MAT) for opioid use disorder MAT delivered by Emergency Medicine (EM) providers can decrease mortality due to OUD; however, there are numerous cited barriers to MAT delivery. We examined the impact of MAT training on these barriers among EM residents in an urban, tertiary care facility with a large EM residency. Training included the scripted and standardized content from the Provider Clinical Support System curriculum. Residents completed pre- and post-training surveys on knowledge, barriers, and biases surrounding OUD. We performed Wilcoxon matched-pairs signed-ranks test to detect statistical differences. Of 74 residents, 49 (66%) completed the pre-training survey, and 34 (69%) of these completed the follow-up survey. Residents reported improved preparedness to treat aspects of OUD across all areas queried, reported decreased perception of barriers to providing MAT, and increased comfort prescribing naloxone, counseling patients, prescribing buprenorphine, and treating opioid withdrawal. A didactic training on MAT was associated with residents reporting improved comfort providing buprenorphine and naloxone. As the wake of morbidity and mortality from both COVID and OUD continue to increase, programs should offer dedicated training on MAT.
Funder
California Academy of Family Physicians Residency Program Collaborative
Committee for Interns and Residents at LAC + USC
Subject
Health Information Management,Health Informatics,Health Policy,Leadership and Management
Reference31 articles.
1. Ahmad, F.B.C.J., Rossen, L.M., and Sutton, P. (2022). Provisional Drug Overdose Death Counts, National Center for Health Statistics.
2. Hedegaard, H.M.A., Spencer, M.R., and Warner, M. (2021). Drug Overdose Deaths in the United States, 1999–2020, National Center for Health Statistics. Vol. NCHS Data Brief, No. 428.
3. “Everything is not right anymore”: Buprenorphine experiences in an era of illicit fentanyl;Silverstein;Int. J. Drug Policy,2019
4. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: A randomized clinical trial;Pantalon;JAMA,2015
5. Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department;Hawk;Ann. Emerg Med.,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献